ID3-directed sonogenetics to enhance osteogenesis and bone defect healing

Abstract

Sonogenetics, a noninvasive approach combining ultrasound physics with genetic engineering, has shown clinical potential in promoting bone repair. However, its therapeutic efficacy remains suboptimal due to the scarcity of bone-specific ultrasound-responsive targets and insufficient modulation of osteogenic signaling pathways. Herein, we investigated the role of the transcriptional repressor inhibitor of DNA binding/differentiation 3 (Id3) in bridging sonogenetics and bone regeneration. RNA sequencing and PCR array analyses revealed significant downregulation of Id3 during low-intensity pulsed ultrasound (LIPUS)-induced bone formation, suggesting Id3 acts as a “brake” on ultrasound-mediated osteogenesis. As a member of the ID protein family, Id3 binds to basic helix-loop-helix (bHLH) transcription factors (e.g., E-proteins) to suppress their DNA-binding capacity and osteogenic gene transcription-particularly in bone marrow-derived mesenchymal stem cells (BMSCs), a key cell type for bone repair. Functional experiments demonstrated that Id3 knockdown enhanced LIPUS-induced osteogenic differentiation of BMSCs in vitro (upregulating RUNX2, OCN) and promoted in vivo bone formation in rodent bone defect models, while Id3 overexpression reversed these effects. Chromatin immunoprecipitation (ChIP) assays confirmed that Id3 directly targets bHLH proteins to inhibit the Bmp/Smad pathway, a core cascade for osteogenesis. Based on these findings, we propose an ID3-based sonogenetic strategy: we engineered an Id3-inhibitory peptide (rID3) targeting the Id3/E2A interface, which would synergize with LIPUS to enhance defect healing of cranial bone. Our work delineates a novel CaN/NFATC3/Id3/E2A/Bmp4 pathway for ultrasound mechanobiology and provides a promising combinatorial therapeutic strategy for precision sonogenetics bone regeneration.

References

[1] Wildemann B, et al.. Non-union bone fractures. Nat. Rev. Dis. Prim., 2021, 7: 57

[2] Xu F, et al.. The role of exosomes derived from various sources in facilitating the healing of chronic refractory wounds. Pharmacol. Res., 2025, 216 107753

[3] Yang B, et al.. Strategies and prospects of effective neural circuits reconstruction after spinal cord injury. Cell Death Dis., 2020, 11: 439

[4] Zhang X, et al.. Divide-and-conquer strategy with engineered ossification center organoids for rapid bone healing through developmental cell recruitment. Nat. Commun., 2025, 16 6200

[5] Feng P, et al.. Structural and functional adaptive artificial bone: materials, fabrications, and properties. Adv. Funct. Mater., 2023, 33: 2214726

[6] Leal C, D’Agostino C, Gomez Garcia S, Fernandez A. Current concepts of shockwave therapy in stress fractures. Int. J. Surg., 2015, 24: 195-200

[7] O’Reilly MA. Exploiting the mechanical effects of ultrasound for noninvasive therapy. Science, 2024, 385 eadp7206

[8] Zhu M, et al.. Sonogenetics in the treatment of chronic diseases: a new method for cell regulation. Adv. Sci., 2024, 11 e2407373

[9] Liu T, et al.. Sonogenetics: Recent advances and future directions. Brain Stimul., 2022, 15: 1308-1317

[10] Wu P, et al.. The principles and promising future of sonogenetics for precision medicine. Theranostics, 2024, 14: 4806-4821

[11] Hahmann J, Ishaqat A, Lammers T, Herrmann A. Sonogenetics for monitoring and modulating biomolecular function by ultrasound. Angew. Chem. (Int. ed. Engl.), 2024, 63: e202317112

[12] Zhang G, Li X, Wu L, Qin YX. Piezo1 channel activation in response to mechanobiological acoustic radiation force in osteoblastic cells. Bone Res., 2021, 9: 16

[13] Ivanovski, F., Jazbec, V., Varda, N., Jerala, R. & Beneina, M. Ultrasound-responsive mammalian cell synthetic biology. IEEE Trans. Ultrason. Ferroelectr. Freq. Control. PP (2025).

[14] Ivanovski F, et al.. Ultrasound-mediated spatial and temporal control of engineered cells in vivo. Nat. Commun., 2024, 15 7369

[15] Jiang X, et al.. A Review Of Low-intensity Pulsed Ultrasound For Therapeutic Applications. IEEE Trans. bio-Med. Eng., 2019, 66: 2704-2718

[16] Munshi, R. How Transcription Factor Clusters Shape The Transcriptional Landscape. Biomolecules14, 875 (2024).

[17] Ma L, et al.. A Janus-ROS healing system promoting infectious bone regeneration via sono-epigenetic modulation. Adv. Mater., 2024, 36 e2307846

[18] Han Y, Gao H, Gao J, Yang Y, He C. Low-intensity pulsed ultrasound regulates bone marrow mesenchymal stromal cells differentiation and inhibits bone loss by activating the IL-11-Wnt/β-catenin signaling pathway. Int. Immunopharmacol., 2024, 143: 113380

[19] Qi L, et al.. Low-intensity focused ultrasound stimulation promotes stroke recovery via astrocytic HMGB1 and CAMK2N1 in mice. Stroke Vasc. Neurol., 2024, 9: 505-518

[20] Zhang, Z. et al. Low-intensity pulsed ultrasound stimulation facilitates in vitro osteogenic differentiation of human adipose-derived stem cells via up-regulation of heat shock protein (HSP)70, HSP90, and bone morphogenetic protein (BMP) signaling pathway. Biosci. Rep. 38, 352 (2018).

[21] Hou CH, Hou SM, Tang CH. Ultrasound increased BMP-2 expression via PI3K, Akt, c-Fos/c-Jun, and AP-1 pathways in cultured osteoblasts. J. Cell. Biochem., 2009, 106: 7-15

[22] Hu L, et al.. Depletion of ID3 enhances mesenchymal stem cells therapy by targeting BMP4 in Sjögren’s syndrome. Cell Death Dis., 2020, 11 172

[23] Huang RL, et al.. IL-6 potentiates BMP-2-induced osteogenesis and adipogenesis via two different BMPR1A-mediated pathways. Cell Death Dis., 2018, 9: 144

[24] Deng Z, et al.. The nuclear factor ID3 endows macrophages with a potent anti-tumour activity. Nature, 2024, 626: 864-873

[25] Schmitz R, et al.. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature, 2012, 490: 116-120

[26] Loveys DA, Streiff MB, Kato GJ. E2A basic-helix-loop-helix transcription factors are negatively regulated by serum growth factors and by the Id3 protein. Nucleic Acids Res., 1996, 24: 2813-2820

[27] Miyazaki M, et al.. The opposing roles of the transcription factor E2A and its antagonist Id3 that orchestrate and enforce the naive fate of T cells. Nat. Immunol., 2011, 12: 992-1001

[28] Jiang H, et al.. ID proteins promote the survival and primed-to-naive transition of human embryonic stem cells through TCF3-mediated transcription. Cell Death Dis., 2022, 13: 549

[29] Samanta J, Kessler JA. Interactions between ID and OLIG proteins mediate the inhibitory effects of BMP4 on oligodendroglial differentiation. Development, 2004, 131: 4131-4142

[30] Ren, X. et al. Gsmtx4 Alleviated Osteoarthritis through Piezo1/Calcineurin/NFAT1 signaling axis under excessive mechanical strain. Int. J. Mol. Sci.24, 4022 (2023).

[31] Athanassiadis AG, et al.. Ultrasound-responsive systems as components for smart materials. Chem. Rev., 2022, 122: 5165-5208

[32] Iacoponi F, et al.. Optimal low-intensity pulsed ultrasound stimulation for promoting anti-inflammatory effects in macrophages. APL Bioeng., 2023, 7 016114

[33] Mizrahi N, et al.. Low intensity ultrasound perturbs cytoskeleton dynamics. Soft Matter, 2012, 8: 2438-2443

[34] Rabut C, et al.. Ultrasound technologies for imaging and modulating neural activity. Neuron, 2020, 108: 93-110

[35] Imashiro C, et al.. Travelling ultrasound promotes vasculogenesis of three-dimensional-monocultured human umbilical vein endothelial cells. Biotechnol. Bioeng., 2021, 118: 3760-3769

[36] Zhou X, et al.. Improved human bone marrow mesenchymal stem cell osteogenesis in 3D bioprinted tissue scaffolds with low intensity pulsed ultrasound stimulation. Sci. Rep., 2016, 6 32876

[37] Tang CH, et al.. Ultrasound stimulates cyclooxygenase-2 expression and increases bone formation through integrin, focal adhesion kinase, phosphatidylinositol 3-kinase, and Akt pathway in osteoblasts. Mol. Pharm., 2006, 69: 2047-2057

[38] Bader KB, et al.. Overview of therapeutic ultrasound applications and safety considerations: 2024 Update. J. Ultrasound Med., 2025, 44: 381-433

[39] Liu P, et al.. Sonogenetic control of multiplexed genome regulation and base editing. Nat. Commun., 2023, 14 6575

[40] Ling F, Kang B, Sun XH. Id proteins: small molecules, mighty regulators. Curr. Top. Dev. Biol., 2014, 110: 189-216

[41] Wang Y, et al.. Tissue-infiltrating alloreactive T cells require Id3 to deflect PD-1-mediated immune suppression during GVHD. Blood, 2024, 143: 166-177

[42] Thal MA, et al.. Ebf1-mediated down-regulation of Id2 and Id3 is essential for specification of the B cell lineage. Proc. Natl. Acad. Sci. USA, 2009, 106: 552-557

[43] Huang L, et al.. Id3 promotes stem cell features and predicts chemotherapeutic response of intrahepatic Cholangiocarcinoma. Hepatology, 2019, 69: 1995-2012

[44] Bohrer C, et al.. The balance of Id3 and E47 determines neural stem/precursor cell differentiation into astrocytes. EMBO J., 2015, 34: 2804-2819

[45] Kowanetz M, Valcourt U, Bergström R, Heldin CH, Moustakas A. Id2 and Id3 define the potency of cell proliferation and differentiation responses to transforming growth factor beta and bone morphogenetic protein. Mol. Cell Biol., 2004, 24: 4241-4254

[46] Peng Y, et al.. Inhibitor of DNA binding/differentiation helix-loop-helix proteins mediate bone morphogenetic protein-induced osteoblast differentiation of mesenchymal stem cells. J. Biol. Chem., 2004, 279: 32941-32949

[47] Xu C, et al.. The microRNA-10a/ID3/RUNX2 axis modulates the development of Ossification of Posterior Longitudinal Ligament. Sci. Rep., 2018, 8 9225

[48] Palanisamy P, Alam M, Li S, Chow SKH, Zheng YP. Low-intensity pulsed ultrasound stimulation for bone fractures healing: a review. J. Ultrasound Med., 2022, 41: 547-563

[49] Busse JW, et al.. Re-evaluation of low intensity pulsed ultrasound in treatment of tibial fractures (TRUST): randomized clinical trial. BMJ, 2016, 355: i5351

[50] Schandelmaier S, et al.. Low intensity pulsed ultrasound for bone healing: systematic review of randomized controlled trials. BMJ, 2017, 356: j656

[51] Lasorella A, Benezra R, Iavarone A. The ID proteins: master regulators of cancer stem cells and tumour aggressiveness. Nat. Rev. Cancer, 2014, 14: 77-91

[52] Huang C, et al.. ID3 enhances PD-L1 expression by restructuring MYC to promote colorectal cancer immune evasion. Proc. Natl. Acad. Sci. USA, 2025, 122 e2423490122

[53] Wei N, et al.. A bibliometric analysis of T cell and atherosclerosis. Front. Immunol., 2022, 13: 948314

[54] Xu D, et al.. A scientometrics analysis and visualization of depressive disorder. Curr. Neuropharmacol., 2021, 19: 766-786

Funding

the National Natural Science Foundation of China (82001067) Scientific Research Common Program of Beijing Municipal Commission of Education (KM202110025009) Beijing Municipal Natural Science Foundation (7232071) the excellent youth talent program of Capital Medical University (KCB2311) Beijing Nova Program (2024009)

the Young Scientist Program of Beiing Stomatological Hospital, Capital Medical University (NO.YSP202408)

the National Natural Science Foundation of China (82030031, 81991504, 92149301, and L2224038) the Beijing Municipal Government grant (Beijing Laboratory of Oral Health, PXM2021-014226-000041) the Beijing Municipal Government (Beijing Scholar Program, PXM2021_014226_000020) the Beijing Municipal Education Commission (119207020201) the Innovation Research Team Project of Beijing Stomatological Hospital, Capital Medical University (CXTD202201) the Chinese Research Unit of Tooth Development and Regeneration, Academy of Medical Sciences (2019-12M-5-031) the Beijing Municipal Colleges and Universities High Level Talents Introduction and Cultivate Project-Beijing Great Wall Scholar Program (CIT&TCD 20180332)

the National Natural Science Foundation of China (82350003)

Rights & permissions

The Author(s)